Page last updated: 2024-12-07
ecgonidine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
ecgonidine: a methylecgonidine metabolite; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 101709 |
SCHEMBL ID | 25660 |
MeSH ID | M0333239 |
Synonyms (10)
Synonym |
---|
anhydroecgonine |
FT-0662192 |
ecgonidine |
(1r)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylic acid |
SCHEMBL25660 |
8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylic acid # |
8-azabicyclo[3.2.1]oct-2-ene-2-carboxylic acid, 8-methyl-, (1r)- |
Q56085723 |
DTXSID00901169 |
8-methyl-8-azabicyclo[3.2.1]oct-2-ene-2-carboxylic acid |
Research Excerpts
Overview
Ecgonidine is a zwitterion and highly water soluble.
Excerpt | Reference | Relevance |
---|---|---|
"Ecgonidine is a zwitterion and highly water soluble." | ( Electron ionization mass fragmentometric detection of urinary ecgonidine, a hydrolytic product of methylecgonidine, as an indicator of smoking cocaine. McWhorter, LK; Paul, BD; Smith, ML, 1999) | 1.27 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 22.90
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.90) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |